Equity
NAUWYNCK MARC paid out €371,929 in dividends. That is 207% of the 2025 profit.
NAUWYNCK MARC paid out €371,929 in dividends. That is 207% of the 2025 profit.
The micro format states no turnover.
Debts rose by €204,660 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Short-term debts rose from €210,871 to €408,531.
The 2024 accounts came 16 days late. The other nine of the last ten were filed on time.
More equity than 90% of companies in human health. The sector median is €125,188, over 21,387 companies.
In July 2024, 20,155 companies had the same profile as NAUWYNCK MARC has now. Each dot stands for 51 companies, two years later.
The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.4% | 0.5% |
| 3 | 0.6% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.4% | 1.6% |
| 7 | 1.7% | 1.8% |
| 8 | 1.9% | 2.0% |
| 9 | 3.1% | 3.3% |
| 10 | 5.9% | 6.4% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,155 companies, not a prediction for NAUWYNCK MARC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
| Company | ||||
|---|---|---|---|---|
| NAUWYNCK MARC Bruges | €1.2m | €281,001 | 65.9% | - |
| Dokter Lieven Vandeputte Bruges | €1.1m | €276,247 | 86.1% | - |
| MEDICALE MARCIL Koksijde | €1.2m | €283,150 | 52.5% | - |
| Dokters BEIRINCKX ANNEMIEKE - BEYNE ARNOLD Damme | €1.3m | €266,117 | 91.5% | - |
| DOKTER BARBARA BUSSELS Ingelmunster | €1.2m | €285,995 | 85.1% | - |
| DOKTER MATTENS Lommel | €1.2m | €266,542 | 74.3% | - |
| Dr. Karen De Coninck, dermatologie Keerbergen | €1.2m | €280,550 | 4.3% | - |
These companies have the same main activity as NAUWYNCK MARC: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.1m and €1.3m, founded between 1999 and 2004.
NAUWYNCK MARC files the micro format. That format states no turnover. The gross margin rose from €141,889 in 2002 to €281,001 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.